Biosciences

‘De-extinction’ startup Colossal Biosciences makes its first acquisition: a company that clones pets

November 4, 2025

The cloning industry is contracting—ironically, perhaps. On Tuesday, Colossal Biosciences announced that it has acquired ViaGen Pets and Equine, an animal cloning firm, marking Colossal’s…

Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle

August 13, 2025

Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, with the Singapore International Commercial Court (SICC) having…

Colossal Biosciences CEO Ben Lamm defends his ‘de-extinct’ dire wolf

April 12, 2025

This week, genomics and biotechnology company Colossal Biosciences unveiled genetically engineered canines—named Romulus, Remus, and Khaleesi—that it calls dire wolves, a species of wolf…